The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
Pooled sgRNA screeningA customized genome-wide library divided into 48 sub-pools was generated in collaboration with the Broad Institute’s Genetic Perturbation Platform (GPP). In...
Researchers have recognized distinctive three-dimensional options known as TULIPs within the genome of posterior fossa group A (PFA) ependymoma, a difficult-to-treat mind tumor...
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) introduced a big addition to its drug pipeline with the acquisition of CT-95 from Hyperlink...
